Half-life measurement of

Half-Life Scandium / chemistry Cyclotrons
(44)Sc (44m)Sc Gamma-spectrometry Half-life Ionization chamber Nuclear data

Journal

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
ISSN: 1872-9800
Titre abrégé: Appl Radiat Isot
Pays: England
ID NLM: 9306253

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 08 07 2022
revised: 30 08 2022
accepted: 01 10 2022
pubmed: 14 10 2022
medline: 8 11 2022
entrez: 13 10 2022
Statut: ppublish

Résumé

The half-lives of

Identifiants

DOI: 10.1016/j.apradiso.2022.110507 PMID: 36228535
pubmed: 36228535
pii: S0969-8043(22)00392-X
doi: 10.1016/j.apradiso.2022.110507
pii:
doi:

Substances chimiques

Scandium YUJ4U1EW7R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110507

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

M Teresa Durán (MT)

Institut de Radiophysique, Lausanne, Switzerland. Electronic address: teresa.duran@chuv.ch.

Frédéric Juget (F)

Institut de Radiophysique, Lausanne, Switzerland.

Youcef Nedjadi (Y)

Institut de Radiophysique, Lausanne, Switzerland.

Claude Bailat (C)

Institut de Radiophysique, Lausanne, Switzerland.

Pascal V Grundler (PV)

Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen-PSI, Switzerland.

Zeynep Talip (Z)

Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen-PSI, Switzerland.

Nicholas P van der Meulen (NP)

Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, Villigen-PSI, Switzerland; Laboratory of Radiochemistry, Paul Scherrer Institute (PSI), Villigen-PSI, Switzerland.

Pierluigi Casolaro (P)

Albert Einstein Center for Fundamental Physics (AEC), Laboratory for High Energy Physics (LHEP), University of Bern, Switzerland.

Gaia Dellepiane (G)

Albert Einstein Center for Fundamental Physics (AEC), Laboratory for High Energy Physics (LHEP), University of Bern, Switzerland.

Saverio Braccini (S)

Albert Einstein Center for Fundamental Physics (AEC), Laboratory for High Energy Physics (LHEP), University of Bern, Switzerland.

Articles similaires

Exploring the Impact of Pharmacological Target-Mediated Low Plasma Exposure in Lead Compound Selection in Drug Discovery - A Modeling Approach.

Min Xu, Duxin Sun, Guohua An
1.00
Drug Discovery Animals Models, Biological Protein Kinase Inhibitors Humans

Prolonging the circulatory half-life of C1 esterase inhibitor via albumin fusion.

Sangavi Sivananthan, Varsha Bhakta, Negin Chaechi Tehrani et al.
1.00
Animals Complement C1 Inhibitor Protein Mice Half-Life Recombinant Fusion Proteins

Development of Predictive Statistical Model for Gaining Valuable Insights in Pharmaceutical Product Recalls.

Jayshil A Bhatt, Kenneth R Morris, Rahul V Haware
1.00
Models, Statistical Machine Learning Drug Recalls Pharmaceutical Preparations Artificial Intelligence

Kinetic analysis of D-Alanine upon oral intake in humans.

Tomonori Kimura, Shinsuke Sakai, Masaru Horio et al.
1.00
Humans Alanine Administration, Oral Male Adult

Classifications MeSH

questionsmedicales.fr › Phénomènes physiques › Temps › Période › Half-life measurement of
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Terres rares › Scandium › Half-life measurement of
questionsmedicales.fr › Équipement et fournitures › Équipement et fournitures pour les applications des radiations › Accélérateurs de particules › Cyclotrons › Half-life measurement of